Products & Services · Total revenues

Other — Total revenues

United Therapeutics Other — Total revenues decreased by 19.7% to $5.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $5.00M to $5.30M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful monetization of secondary assets or emerging business lines, while a decrease suggests a decline in non-core operations or a strategic shift away from these activities.

Detailed definition

This metric represents the total gross income generated by the company's non-core or miscellaneous business segments tha...

Peer comparison

Peers often report this as 'Other Revenue' or 'Non-Core Segment Revenue', which typically represents a small fraction of total corporate revenue.

Metric ID: uthr_segment_other_total_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$10.00M$0.00$0.00$3.80M$2.50M$3.50M$1.90M$3.90M$6.20M$4.90M$5.50M$5.50M$5.00M$5.50M$6.90M$6.60M$5.30M
QoQ Change-100.0%-34.2%+40.0%-45.7%+105.3%+59.0%-21.0%+12.2%+0.0%-9.1%+10.0%+25.5%-4.3%-19.7%
YoY Change-75.0%+2.6%+148.0%+40.0%+189.5%+41.0%-19.4%+12.2%+25.5%+20.0%+6.0%
Range$0.00$10.00M
Avg YoY Growth+35.5%
Median YoY Growth+20.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is United Therapeutics's other — total revenues?
United Therapeutics (UTHR) reported other — total revenues of $5.30M in Q1 2026.
How has United Therapeutics's other — total revenues changed year-over-year?
United Therapeutics's other — total revenues increased by 6.0% year-over-year, from $5.00M to $5.30M.
What does other — total revenues mean?
The total revenue generated by the company's secondary or non-core business segments.